By Katherine Hamilton
PepGen reported mixed results for its trial of a muscle-disorder treatment. Shares fell 42% to $2.44 in after-hours trading Monday.
Phreesia cut its fiscal year 2027 revenue guidance. The stock slid 23% to $8.80 after the bell.
Virgin Galactic narrowed its loss in the fourth quarter. Shares rose 9% to $2.37.
Write to Katherine Hamilton at katherine.hamilton@wsj.com
(END) Dow Jones Newswires
March 30, 2026 19:05 ET (23:05 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.